The Technical Analyst
iShares U.S. [IHE]
Exchange: NYSE
iShares U.S. Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.54% $65.68
America/New_York / 8 mai 2024 @ 15:59
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 656.51 mill |
| EPS: | 10.11 |
| P/E: | 6.49 |
| Earnings Date: | N/A |
| SharesOutstanding: | 10.00 mill |
| Avg Daily Volume: | 0.0747 mill |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.27x |
| Company: PE 6.49 | sector: PE 23.85 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.48x |
| Company: PE 6.49 | industry: PE 13.52 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 64.98 - 66.38 ( +/- 1.07%) |
| ATR Model: 14 days |
Forecast:
16:00 - $65.68
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $65.68
Forecast 2: 16:00 - $65.68
Forecast 3: 16:00 - $65.68
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $65.68 (0.54% ) |
| Volume | 0.0314 mill |
| Avg. Vol. | 0.0747 mill |
| % of Avg. Vol | 42.00 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For IHE
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
IHE
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.
Latest Press Releases
2020-01-29 16:21:00 - Press Release
Hyland Healthcare Demonstrates Enhanced Interoperability At Integrating The Healthcare Enterprise (ihe) Connectathon
Cleveland, jan. 29, 2020 /prnewswire/ -- at the 2020 ihe north american connectathon in cleveland, hyland healthcare successfully demonstrated the interoperability of its onbase healthcare content services platform and its suite of enterprise imaging solutions including, acuo vendor…
Latest News
2024-05-07 12:31:03 - Zacks Investment Research
A Look at Pharma ETFs Post Q1 Earnings
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
2024-04-17 11:00:19 - Zacks Investment Research
JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus
Johnson & Johnson (JNJ) continued with its long streak of earnings beat but lagged revenue estimates.
2024-04-15 07:20:36 - Zacks Investment Research
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
The iShares U.S. Pharmaceuticals ETF (IHE) was launched on 05/01/2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity market.
2024-04-10 09:27:00 - Market Watch
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
A new exchange-traded fund needs an edge to attract investors. This might be its industry focus — a tall order in a crowded market with ETFs covering just about any industry you can imagine.
2024-04-04 08:01:07 - Zacks Investment Research
Time to Tap Healthcare ETFs on Nvidia's AI Ambition?
At Nvidia's last week's GTC AI conference, the company announced partnerships in the healthcare sector, representing a strategic move toward expanding its revenue streams beyond tech sectors.
2024-02-23 14:01:06 - Zacks Investment Research
Looking for Bargain Hunting? Top-Ranked ETFs to Buy
Bargain hunting in a market where the S&P 500 is at record levels may seem like a daunting task, but it's not impossible.
2024-02-16 09:46:03 - Zacks Investment Research
5 ETFs at All-Time Highs as S&P 500 Rally Continues
The S&P 500 hit an all-time high on Thursday despite despite a weaker-than-expected retail sales report.
2024-02-13 07:21:19 - Zacks Investment Research
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the iShares U.S. Pharmaceuticals ETF (IHE) is a passively managed exchange traded fund launched on 05/01/2006.
2024-02-12 14:01:05 - Zacks Investment Research
A Look at Pharma ETFs After Q4 Earnings
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth. However, many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
2024-02-07 01:40:24 - Zacks Investment Research
Pharma ETF (IHE) Hit a 52-Week High
Investors seeking momentum may have iShares U.S. Pharmaceuticals ETF IHE on radar now. The fund recently hit a new 52-week high.